Enter at least 4 characters

1 results showing for: 'emtricitabine with tenofovir disoproxil'

Emtricitabine with tenofovir disoproxil    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 112.
- Up to 30 tab available on a PSO
- Subsidy by endorsement
  • 3 to 6 month supply. Tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a fumarate)
    • Brand Fully subsidised brand. Tenofovir Disoproxil Emtricitabine Mylan Unapproved medicine supplied under Section 29.
    • Pharmacode2719495
    • Subsidy $13.45
    • Measure / Qty per 30
  • 3 to 6 month supply. Tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a maleate)
    • Brand Fully subsidised brand. Tenofovir Disoproxil Emtricitabine Viatr
    • Pharmacode2638088
    • Subsidy $13.45
    • Measure / Qty per 30

Note: HIV treatment with antiretroviral medicines should only be initiated under the guidance of a clinician experienced in the management of HIV. Practitioners should refer to local health pathways and guidelines.

Note: Post-Exposure Prophylaxis (PEP) is not a registered indication for emtricitabine with tenofovir disoproxil and it cannot be supplied for this use under a standing order.

Funded on PSO for Post-Exposure Prophylaxis (PEP) only, supplied only by an authorised practitioner, and the PSO is endorsed accordingly.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply